About inclisiran
Small interfering RNA lipid-lowering medicine
Used for
- Lowers LDL cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia, alongside diet and other lipid-lowering treatment.
Usual adult dose
284 mg injected under the skin initially, again at 3 months, then every 6 months.
Common side effects
- Injection-site reactions
- Joint pain
- Urinary tract infection
- Bronchitis
Important warnings
- Use alongside a cholesterol-lowering diet and other indicated treatment.
- Injection-site reactions may include pain, redness, or rash.
- It is not established for children.
Pregnancy
Human pregnancy information is limited; use during pregnancy is generally not recommended.
Breastfeeding
It is unknown whether inclisiran passes into breast milk; effects on a nursing infant are uncertain.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.